ArticleJournal of cancer prevention2026
Ethnic Heterogeneity in Reproductive Risk Factors for Breast Cancer, With a Focus on Asian Populations: A Meta-analysis.
Article in Journal of cancer prevention, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to examine differences in the association between reproductive factors and breast cancer (BC) risk across ethnic groups, particularly Asians and non-Asians, and to explore temporal trends through meta-analysis. The study focused on epidemiologic research published up to August 31, 2022, examining reproductive factors related to BC risk and family history. All effect sizes were calculated using a random-effect model. The protective effect of the higher number of childbirths against BC was stronger in Asians than in Europeans or Americans (childbirths ≥ 2 vs. 1; Asians, relative risk [RR]: 0.66, 95% CI: 0.59-0.74; Europeans, RR: 0.89, 95% CI: 0.86-0.92; Americans, RR: 0.91, 95% CI: 0.87-0.96). Similarly, the effect of high parity was more pronounced in Asians than in Americans and Europeans (Asians, RR: 0.72, 95% CI: 0.58-0.89; Europeans, RR: 0.81, 95% CI: 0.74-0.88; Americans, RR: 0.84, 95% CI: 0.76-0.92). In contrast, no significant differences among populations were found in BC risks associated with combined hormone replacement therapy use. While the association between family history and BC risk appeared to differ by ethnicity, no temporal change was observed (< 2010, RR: 1.58, 95% CI: 1.40-1.78; ≥ 2010, RR: 1.57, 95% CI: 1.46-1.67). These results suggest that some reproductive factors associated with BC differ across ethnicities and time trends, perhaps due to the prevalence of reproductive factors and the baseline hazard of BC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.